List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 199 studies with search of: "Lenalidomide"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Multi-Center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia;   CLL;   Untreated;   Front-Line;   First-Line;   Initial Therapy
Interventions: Drug: Lenalidomide and Rituximab;   Drug: Lenalidomide and Rituximab
2 Recruiting Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
Condition: Cutaneous Lupus Erythematosus (CLE)
Intervention: Drug: lenalidomide (Revlimid®)
3 Recruiting Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide;   Drug: Lenalidomide
4 Active, not recruiting A Study of Revlimid for Treatment of Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin's
Interventions: Drug: lenalidomide;   Drug: lenalidomide
5 Recruiting Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Intervention: Drug: lenalidomide-low dose dexamethasone plus rituximab
6 Recruiting Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)
Condition: Graft-Versus-Host Disease
Intervention: Drug: Lenalidomide
7 Recruiting Study to Determine Efficacy and Safety of Lenalidomide Plus Low-Dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide and low-dose dexamethasone;   Drug: Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles;   Drug: Melphalan, Prednisone and Thalidomide
8 Recruiting Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
Condition: Malignant Gliomas
Interventions: Drug: Irinotecan;   Drug: Lenalidomide
9 Recruiting The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality
Condition: Myelodysplastic Syndromes
Intervention: Drug: lenalidomide
10 Completed Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: Lenalidomide;   Drug: Dacarbazine
11 Completed Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
Condition: Complex Regional Pain Syndrome, Type I
Interventions: Drug: lenalidomide (CC-5013);   Drug: Placebo
12 Recruiting Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide
13 Recruiting Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Conditions: Chronic Lymphocytic Leukemia;   Non-Hodgkin's Lymphoma
Interventions: Drug: bendamustine and lenalidomide;   Drug: BL-NHL;   Drug: BLR-CLL;   Drug: BLR-NHL
14 Recruiting Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis
Condition: Amyloidosis
Interventions: Drug: cyclophosphamide;   Drug: lenalidomide;   Drug: dexamethasone
15 Recruiting Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Intervention: Drug: Lenalidomide (Revlimid®)
16 Terminated A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Condition: B-Cell Lymphoma
Intervention: Drug: CC-5013 (lenalidomide)
17 Not yet recruiting Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: Lenalidomide;   Drug: Gemcitabine
18 Completed A Study of Oral CC-5013 (Lenalidomide; Revlimid) in Myelodysplastic Syndromes
Condition: Myelodysplastic Syndrome (MDS)
Interventions: Drug: Lenalidomide (CC-5013);   Drug: Erythropoietin (rhu-EPO)
19 Suspended Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malig Who Relapse/Progress After Rituximab
Conditions: Lymphocytic Leukemia;   Mantle Cell Lymphoma
Intervention: Drug: Lenalidomide (REVLIMID®)
20 Recruiting Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Lenalidomide;   Drug: Rituximab

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services